Maddi Hebebrand, MC, Associate Editor

Explore the top headlines of the week, including insights on the latest clinical trials, therapeutic updates, and more.

This week, we feature top articles from our sister publications on regulatory updates, clinical trial insights, and more.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Test your knowledge of key words and terms associated with dermatology news from the last month.

Advances in biologics and systemics have reshaped the lives of patients with psoriasis, offering clearer skin and joint protection.

Dermatology Times is recapping our exclusive expert interviews from the month of August.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

GLP-1 receptor agonists may indirectly affect dermatologic outcomes by targeting inflammation and metabolic comorbidities.

Learn more about the in-depth topics covered in the August 2025 print issue of Dermatology Times.

Case reports showed encouraging outcomes in eczema, but the company is pursuing deeper validation.

Explore the top headlines of the month, including insights on regulatory updates, expert pearls, and more.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Roundtable participants agreed the art of psoriasis management lies in aligning biologic or oral options with patient comorbidities, lifestyle, and insurance coverage.

The test now provides 3 validated insights: risk of metastasis, response to ART, and risk of recurrence.

Explore the top headlines of the week, including insights on the latest clinical trials, therapeutic updates, and more.

This week, we feature top articles from our sister publications on regulatory updates, clinical trial insights, and more.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Omar Noor leads a dynamic discussion on personalized psoriasis therapy, addressing patient challenges and innovative treatment options.

Clinicians explore innovative strategies for managing atopic dermatitis, emphasizing personalized care and the use of non-steroidal treatments for improved patient outcomes.

Mentors and mentees include specialists in complex medical dermatology, pediatric dermatology, and procedural dermatology to diversify trial opportunities.

Strong mentorship provides resilience for young clinicians navigating evolving challenges in practice.

Art Garfunkel raises awareness about psoriasis, sharing his journey and the impact of tildrakizumab treatment in a campaign for support and hope.

The randomized, placebo-controlled trial will evaluate safety, tolerability, pharmacokinetics, and pharmacodynamics in up to 150 healthy volunteers.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Oversight and endorsement from trusted clinicians were consistent patient requirements for integrating both AI and telemedicine.

Karen McGuire, PhD, discusses TAMES-02, a clinical trial evaluating TolaSure for Epidermolysis Bullosa Simplex.

Expanded prescribing rights for pharmacists could ease treatment delays and improve access for AD patients.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Orphan designation provides Soligenix with potential regulatory, financial, and exclusivity benefits as it develops SGX945.

Explore the top headlines of the week, including insights on the latest clinical trials, therapeutic updates, and more.